Skip to main content
. 2017 Jul 12;8(44):76204–76213. doi: 10.18632/oncotarget.19211

Table 5. Location of JAK2V617F mutation in heterozygous JAK2 46/1 haplotype MPN patients.

Category Case no. On 46/1 allele P value
All MPNs 37 32 (86%) 7.428 × 10-6
PV 9 8 (89%) 0.039
ET 27 23 (85%) 3.107 × 10-4

ET, essential thrombocythemia; MPN, myeloproliferative neoplasm; no., number; PV, polycythemia vera.